| Negative symptoms of schizophrenia: new developments and unanswered research questions S Galderisi, A Mucci, RW Buchanan, C Arango The Lancet Psychiatry 5 (8), 664-677, 2018 | 576 | 2018 |
| The influence of illness‐related variables, personal resources and context‐related factors on real‐life functioning of people with schizophrenia S Galderisi, A Rossi, P Rocca, A Bertolino, A Mucci, P Bucci, P Rucci, ... World Psychiatry 13 (3), 275-287, 2014 | 493 | 2014 |
| EEG microstate duration and syntax in acute, medication-naive, first-episode schizophrenia: a multi-center study D Lehmann, PL Faber, S Galderisi, WM Herrmann, T Kinoshita, ... Psychiatry Research: Neuroimaging 138 (2), 141-156, 2005 | 417 | 2005 |
| Sources of cortical rhythms in adults during physiological aging: a multicentric EEG study C Babiloni, G Binetti, A Cassarino, G Dal Forno, C Del Percio, F Ferreri, ... Human brain mapping 27 (2), 162-172, 2006 | 361 | 2006 |
| The cortical generators of P3a and P3b: a LORETA study U Volpe, A Mucci, P Bucci, E Merlotti, S Galderisi, M Maj Brain research bulletin 73 (4-6), 220-230, 2007 | 341 | 2007 |
| Oxytocin receptor polymorphisms and adult attachment style in patients with depression B Costa, S Pini, P Gabelloni, M Abelli, L Lari, A Cardini, M Muti, C Gesi, ... Psychoneuroendocrinology 34 (10), 1506-1514, 2009 | 305 | 2009 |
| Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis S Galderisi, P Rucci, B Kirkpatrick, A Mucci, D Gibertoni, P Rocca, A Rossi, ... JAMA psychiatry 75 (4), 396-404, 2018 | 285 | 2018 |
| Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome S Galderisi, P Bucci, A Mucci, B Kirkpatrick, S Pini, A Rossi, A Vita, M Maj Schizophrenia research 147 (1), 157-162, 2013 | 224 | 2013 |
| Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial S Galderisi, A Mucci, I Bitter, J Libiger, P Bucci, WW Fleischhacker, ... European Neuropsychopharmacology 23 (3), 196-204, 2013 | 219 | 2013 |
| EPA guidance on assessment of negative symptoms in schizophrenia S Galderisi, A Mucci, S Dollfus, M Nordentoft, P Falkai, S Kaiser, ... European Psychiatry 64 (1), e23, 2021 | 209 | 2021 |
| Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 205 | 2018 |
| Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study S Galderisi, M Maj, A Mucci, GB Cassano, G Invernizzi, A Rossi, A Vita, ... American Journal of Psychiatry 159 (6), 983-990, 2002 | 195 | 2002 |
| Primary and persistent negative symptoms: concepts, assessments and neurobiological bases A Mucci, E Merlotti, A Üçok, A Aleman, S Galderisi Schizophrenia research 186, 19-28, 2017 | 174 | 2017 |
| Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback A Mucci, D Dima, A Soricelli, U Volpe, P Bucci, S Frangou, A Prinster, ... Psychological medicine 45 (8), 1765-1778, 2015 | 161 | 2015 |
| Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study S Galderisi, M Davidson, RS Kahn, A Mucci, H Boter, MD Gheorghe, ... Schizophrenia research 115 (2-3), 104-114, 2009 | 160 | 2009 |
| EPA guidance on treatment of negative symptoms in schizophrenia S Galderisi, S Kaiser, I Bitter, M Nordentoft, A Mucci, M Sabé, ... European Psychiatry 64 (1), e21, 2021 | 149 | 2021 |
| European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia A Vita, W Gaebel, A Mucci, G Sachs, A Erfurth, S Barlati, F Zanca, ... European Psychiatry 65 (1), e58, 2022 | 144 | 2022 |
| Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia S Galderisi, M Quarantelli, U Volpe, A Mucci, GB Cassano, G Invernizzi, ... Schizophrenia bulletin 34 (2), 393-401, 2008 | 141 | 2008 |
| Factors associated with real-life functioning in persons with schizophrenia in a 4-year follow-up study of the Italian network for research on psychoses A Mucci, S Galderisi, D Gibertoni, A Rossi, P Rocca, A Bertolino, ... JAMA psychiatry 78 (5), 550-559, 2021 | 136 | 2021 |
| Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia AO Ahmed, B Kirkpatrick, S Galderisi, A Mucci, A Rossi, A Bertolino, ... Schizophrenia bulletin 45 (2), 305-314, 2019 | 134 | 2019 |
Stefano Pini, MD, PhDProfessor of Psychiatry, Department of Psychiatry, University of Pisa, Pisa, ItalyBestätigte E-Mail-Adresse bei med.unipi.it
